Treace Medical Concepts Inc
NASDAQ:TMCI
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Treace Medical Concepts Inc
NASDAQ:TMCI
|
93m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
128.8B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102.5B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.5B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.4B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
33.6B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Treace Medical Concepts Inc
Glance View
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. The company is headquartered in Ponte Vedra, Florida and currently employs 248 full-time employees. The company went IPO on 2021-04-23. The firm is focused on strategic product development activities that improve surgical efficiencies and patient outcomes. The firm's proprietary Lapiplasty 3-dimensional (3D) Bunion Correction System, which is a combination of instruments, implants and surgical methods designed to correct all three dimensions of the bunion deformity, address the root cause of the bunion deformity. The Lapiplasty System combines novel surgical approach, the Lapiplasty Procedure, with its procedural instrumentation and single-use implant kits. The Lapiplasty Procedure is designed to rotate the entire metatarsal bone into normal anatomical position in all three dimensions, eliminating the bump and restoring normal anatomy. The Lapiplasty Procedure can be performed in either hospital outpatient or ambulatory surgery center settings. The firm's brands include Lapiplasty, Fast Grafter and Plantar Python.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Treace Medical Concepts Inc is 79.9%, which is below its 3-year median of 80.6%.
Over the last 3 years, Treace Medical Concepts Inc’s Gross Margin has decreased from 81.4% to 79.9%. During this period, it reached a low of 79.9% on Sep 30, 2025 and a high of 81.4% on Sep 30, 2022.
